Evidence map›Paper›PMID 40076380›Full record

ArticleMolecules (Basel, Switzerland)2025

A Network Pharmacology Study and In Vitro Evaluation of the Bioactive Compounds of

Ying Wang, Shuizhu Cai, Wenzhao Wen, Yanhui Tan, Wenwen Wang, Jing Xu, Ping Xiong

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. The Application Prospects and Future Outlook ofDrug design, development and therapy · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying WangDepartment of Pharmaceutical Engineering, South China Agricultural University, Guangzhou 510642, China.
Shuizhu CaiDepartment of Pharmaceutical Engineering, South China Agricultural University, Guangzhou 510642, China.
Wenzhao WenDepartment of Pharmaceutical Engineering, South China Agricultural University, Guangzhou 510642, China.
Yanhui TanDepartment of Pharmaceutical Engineering, South China Agricultural University, Guangzhou 510642, China.
Wenwen WangDepartment of Pharmaceutical Engineering, South China Agricultural University, Guangzhou 510642, China.
Jing XuDepartment of Pharmaceutical Engineering, South China Agricultural University, Guangzhou 510642, China.
Ping XiongDepartment of Pharmaceutical Engineering, South China Agricultural University, Guangzhou 510642, China.

Funding

Co-construction program of Agricultural Science and Technology, Guangdong, China 4900-E23032Science and Technology Planning Project of Guangdong Province, China 2015A020209134Science and Technology Planning Project of Guangzhou, China 201604020171
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2Hypoglycemic AgentsNetwork PharmacologyPlant ExtractsPlant LeavesHep G2 CellsHumansMolecular Docking SimulationProto-Oncogene Proteins c-aktSignal TransductionHypoglycemic AgentsPlant ExtractsProto-Oncogene Proteins c-aktantidiabeticKadsura coccineamolecular dockingnetwork pharmacology

Identifiers

PMID40076380
PMCPMC11901907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.